Palatin has a research program in DR, and more specifically, in diabetic macular edema (DME), a complication of DR that ...

The agreement with Palatin follows a $1bn deal with Re-Vana earlier this year as Boehringer targets the ophthalmology market.

For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy, according to a review published online Aug. 14 in JAMA Ophthalmology.

Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and ...

Comprehensive eye exams are vital for detecting early signs of systemic diseases like diabetes, hypertension, and high ...

The NEW DAY study evaluating Iluvien for diabetic macular edema did not meet its primary endpoint, but showed favorable ...

As we grow older, so does our body, and after 45, many health issues catch up. However, these signals develop gradually, so ...

Researchers urged caution, recommending that diabetic patients on GLP-1 therapies undergo regular eye screening….

RegenXBio ( ($RGNX) ) has issued an announcement. On August 18, 2025, REGENXBIO announced that the FDA has extended the review timeline for its ...

THE Georgetown Public Hospital Corporation (GPHC) has been promoting vision care through early screenings and tests at its eye clinic and the Vision Centre.

Ranibizumab's indications encompass the treatment of patients with Neovascular (Wet) Age-Related Macular Degeneration, and ...

Novo Nordisk, the manufacturer of Ozempic, is facing a lawsuit over alleged vision problems caused by the drug ...